Boston Scientific Corp. (NYSE: BSX) shares hit a decade high Wednesday, spiking as much as 11.73 percent ($2.31) to $22 in afternoon trading, the highest the stock has been since the weeks after Boston Scientific closed on its $27.2 billion acquisition of Guidant in April 2006, a move that saddled the company with enormous debt. Read More
